134 related articles for article (PubMed ID: 10619630)
1. Beta-estradiol attenuate amyloid beta-peptide toxicity via nicotinic receptors.
Svensson AL; Nordberg A
Neuroreport; 1999 Nov; 10(17):3485-9. PubMed ID: 10619630
[TBL] [Abstract][Full Text] [Related]
2. Relationship between the increased cell surface alpha7 nicotinic receptor expression and neuroprotection induced by several nicotinic receptor agonists.
Jonnala RR; Buccafusco JJ
J Neurosci Res; 2001 Nov; 66(4):565-72. PubMed ID: 11746376
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of chronic drug treatment on alpha3* and alpha7 nicotinic receptor binding sites, in hippocampal neurones and SH-SY5Y cells.
Ridley DL; Rogers A; Wonnacott S
Br J Pharmacol; 2001 Aug; 133(8):1286-95. PubMed ID: 11498514
[TBL] [Abstract][Full Text] [Related]
4. A novel nicotinic mechanism underlies β-amyloid-induced neurotoxicity.
Liu Q; Xie X; Emadi S; Sierks MR; Wu J
Neuropharmacology; 2015 Oct; 97():457-63. PubMed ID: 25959067
[TBL] [Abstract][Full Text] [Related]
5. Tacrine and donepezil attenuate the neurotoxic effect of A beta(25-35) in rat PC12 cells.
Svensson AL; Nordberg A
Neuroreport; 1998 May; 9(7):1519-22. PubMed ID: 9631459
[TBL] [Abstract][Full Text] [Related]
6. Nicotinic receptor stimulation protects neurons against beta-amyloid toxicity.
Kihara T; Shimohama S; Sawada H; Kimura J; Kume T; Kochiyama H; Maeda T; Akaike A
Ann Neurol; 1997 Aug; 42(2):159-63. PubMed ID: 9266724
[TBL] [Abstract][Full Text] [Related]
7. Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells.
Riganti L; Matteoni C; Di Angelantonio S; Nistri A; Gaimarri A; Sparatore F; Canu-Boido C; Clementi F; Gotti C
Br J Pharmacol; 2005 Dec; 146(8):1096-109. PubMed ID: 16273122
[TBL] [Abstract][Full Text] [Related]
8. Cotinine binding to nicotinic acetylcholine receptors in bovine chromaffin cell and rat brain membranes.
Vainio PJ; Tuominen RK
Nicotine Tob Res; 2001 May; 3(2):177-82. PubMed ID: 11403732
[TBL] [Abstract][Full Text] [Related]
9. Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptors.
Arias E; Gallego-Sandín S; Villarroya M; García AG; López MG
J Pharmacol Exp Ther; 2005 Dec; 315(3):1346-53. PubMed ID: 16144975
[TBL] [Abstract][Full Text] [Related]
10. Time and brain region specific up-regulation of low affinity neuronal nicotinic receptors during chronic nicotine administration in mice.
Nuutinen S; Ahtee L; Tuominen RK
Eur J Pharmacol; 2005 May; 515(1-3):83-9. PubMed ID: 15894304
[TBL] [Abstract][Full Text] [Related]
11. The alpha7 nicotinic acetylcholine receptor-selective antagonist, methyllycaconitine, partially protects against beta-amyloid1-42 toxicity in primary neuron-enriched cultures.
Martin SE; de Fiebre NE; de Fiebre CM
Brain Res; 2004 Oct; 1022(1-2):254-6. PubMed ID: 15353238
[TBL] [Abstract][Full Text] [Related]
12. Nicotinic acetylcholine receptor antagonists alter the function and expression of serine racemase in PC-12 and 1321N1 cells.
Singh NS; Paul RK; Ramamoorthy A; Torjman MC; Moaddel R; Bernier M; Wainer IW
Cell Signal; 2013 Dec; 25(12):2634-45. PubMed ID: 24012499
[TBL] [Abstract][Full Text] [Related]
13. Effects of donepezil treatment on rat nicotinic acetylcholine receptor levels in vivo and in vitro.
Reid RT; Sabbagh MN
J Alzheimers Dis; 2003 Dec; 5(6):429-36. PubMed ID: 14757932
[TBL] [Abstract][Full Text] [Related]
14. Nicotinic receptor agonists and antagonists increase sAPPalpha secretion and decrease Abeta levels in vitro.
Mousavi M; Hellström-Lindahl E
Neurochem Int; 2009; 54(3-4):237-44. PubMed ID: 19111588
[TBL] [Abstract][Full Text] [Related]
15. Mecamylamine prevents tolerance but enhances whole brain [3H]epibatidine binding in response to repeated nicotine administration in rats.
McCallum SE; Caggiula AR; Booth S; Breese CR; Lee MJ; Donny EC; Leonard S; Sved AF
Psychopharmacology (Berl); 2000 May; 150(1):1-8. PubMed ID: 10867970
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effects of donepezil through inhibition of GSK-3 activity in amyloid-beta-induced neuronal cell death.
Noh MY; Koh SH; Kim Y; Kim HY; Cho GW; Kim SH
J Neurochem; 2009 Mar; 108(5):1116-25. PubMed ID: 19077054
[TBL] [Abstract][Full Text] [Related]
17. Chronic ethanol treatment decreases [3H]epibatidine and [3H]nicotine binding and differentially regulates mRNA levels of nicotinic acetylcholine receptor subunits expressed in M10 and SH-SY5Y neuroblastoma cells.
Gorbounova O; Svensson AL; Jönsson P; Mousavi M; Miao H; Hellström-Lindahl E; Nordberg A
J Neurochem; 1998 Mar; 70(3):1134-42. PubMed ID: 9489734
[TBL] [Abstract][Full Text] [Related]
18. Epibatidine binding sites and activity in the spinal cord.
Khan IM; Yaksh TL; Taylor P
Brain Res; 1997 Apr; 753(2):269-82. PubMed ID: 9125412
[TBL] [Abstract][Full Text] [Related]
19. alpha7 Nicotinic receptor gene delivery into mouse hippocampal neurons leads to functional receptor expression, improved spatial memory-related performance, and tau hyperphosphorylation.
Ren K; Thinschmidt J; Liu J; Ai L; Papke RL; King MA; Hughes JA; Meyer EM
Neuroscience; 2007 Mar; 145(1):314-22. PubMed ID: 17218065
[TBL] [Abstract][Full Text] [Related]
20. Effect of amyloid peptides on the increase in TrkA receptor expression induced by nicotine in vitro and in vivo.
Li XD; Arias E; Jonnala RR; Mruthinti S; Buccafusco JJ
J Mol Neurosci; 2005; 27(3):325-36. PubMed ID: 16280603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
